magnolol has been researched along with Cholera Infantum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ren, AM; Sun, LN; Wang, H; Yang, TC; Zhang, SW | 1 |
1 other study(ies) available for magnolol and Cholera Infantum
Article | Year |
---|---|
Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediators.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Chemokine CCL2; Disease Models, Animal; Gastrointestinal Diseases; Gastrointestinal Motility; Ileum; Inflammation Mediators; Interleukin-10; Lignans; Lipopolysaccharides; Male; Malondialdehyde; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; RNA, Messenger; Sepsis; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2008 |